Monte Rosa Therapeutics's total assets for Q2 2025 were $359.59M, a decrease of -8.55% from the previous quarter. GLUE total liabilities were $91.51M for the fiscal quarter, a -22.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.